1. Home
  2. PCRX vs EAF Comparison

PCRX vs EAF Comparison

Compare PCRX & EAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCRX
    SELLHOLDBUYas of a day ago
  • EAF
    SELLHOLDBUYas of a day ago
  • Stock Information
  • Founded
  • PCRX 2006
  • EAF 1886
  • Country
  • PCRX United States
  • EAF United States
  • Employees
  • PCRX N/A
  • EAF N/A
  • Industry
  • PCRX Biotechnology: Pharmaceutical Preparations
  • EAF Industrial Machinery/Components
  • Sector
  • PCRX Health Care
  • EAF Energy
  • Exchange
  • PCRX Nasdaq
  • EAF Nasdaq
  • Market Cap
  • PCRX 604.7M
  • EAF 514.3M
  • IPO Year
  • PCRX 2011
  • EAF 1995
  • Fundamental
  • Price
  • PCRX $18.63
  • EAF $1.76
  • Analyst Decision
  • PCRX Buy
  • EAF Hold
  • Analyst Count
  • PCRX 10
  • EAF 6
  • Target Price
  • PCRX $26.60
  • EAF $1.80
  • AVG Volume (30 Days)
  • PCRX 832.4K
  • EAF 1.7M
  • Earning Date
  • PCRX 02-27-2025
  • EAF 02-12-2025
  • Dividend Yield
  • PCRX N/A
  • EAF N/A
  • EPS Growth
  • PCRX N/A
  • EAF N/A
  • EPS
  • PCRX N/A
  • EAF N/A
  • Revenue
  • PCRX $694,957,000.00
  • EAF $541,710,000.00
  • Revenue This Year
  • PCRX $4.94
  • EAF N/A
  • Revenue Next Year
  • PCRX N/A
  • EAF $4.97
  • P/E Ratio
  • PCRX N/A
  • EAF N/A
  • Revenue Growth
  • PCRX 4.40
  • EAF N/A
  • 52 Week Low
  • PCRX $11.16
  • EAF $0.52
  • 52 Week High
  • PCRX $35.95
  • EAF $2.53
  • Technical
  • Relative Strength Index (RSI)
  • PCRX 49.01
  • EAF 46.20
  • Support Level
  • PCRX $18.27
  • EAF $1.68
  • Resistance Level
  • PCRX $19.45
  • EAF $1.84
  • Average True Range (ATR)
  • PCRX 0.81
  • EAF 0.15
  • MACD
  • PCRX -0.22
  • EAF -0.00
  • Stochastic Oscillator
  • PCRX 21.20
  • EAF 35.96

Stock Price Comparison Chart: PCRX vs EAF

PCRX
EAF
AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober20250102030405060708090PCRX VS EAF

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company has three commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve.

About EAF GrafTech International Ltd.

GrafTech International Ltd is a manufacturer of high-quality graphite electrode products essential to the production of EAF steel and other ferrous and non-ferrous metals. The company has only reportable segment, Industrial Materials, is comprised of its two major product categories: graphite electrodes and petroleum needle coke products. Petroleum needle coke is key raw material used in the production of graphite electrodes.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use